Diseases Treated
The Leader in
Cord Blood Banking
CBR is the family bank with the largest number of transplants and has provided the most cord blood samples for use in new treatments for brain injury and juvenile diabetes.
Thousands of families choose CBR based upon our long history of success, advanced technology, and unparalleled experience.
Watch Now
Girls Own Cord Blood Used to Treat Her Brain Injury
"Stem cells certainly can rejuvenate tissue" said
Dr. Manny Alvarez,
FOX News medical correspondent and health editor, "this is a miracle."
View Story
Using Cord Blood in Regenerative Medicine
"It's not science fiction anymore. I believe that it's very real" states a
leading pediatric neurosurgeon, Dr. Baumgartner
Watch Now
Diseases Treated with Stem Cells
Since 1988, doctors have been using cord blood in lifesaving treatments. Stem cell research holds so much promise that the number of diseases and injuries being treated is growing rapidly.
Current Stem Cell Applications
- Acute Biphenotypic Leukemia
- Acute Lymphocytic Leukemia (ALL)
- Acute Myelogenous Leukemia (AML)
- Acute Undifferentiated Leukemia
- Adult T Cell Leukemia/Lymphoma
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Hodgkin's Lymphoma
- Juvenile Chronic Myelogenous Leukemia (JCML)
- Juvenile Myelomonocytic Leukemia (JMML)
- Multiple Myeloma
- Myeloid/Natural Killer (NK) Cell Precursor Acute Leukemia
- Non-Hodgkin's Lymphoma
- Prolymphocytic Leukemia
- Plasma Cell Leukemia
- Waldenstrom's Macroglobulinemia
- Brain Tumors
- Ewing Sarcoma
- Neuroblastoma
- Ovarian Cancer
- Renal Cell Carcinoma
- Rhabdomyosarcoma
- Small-Cell Lung Cancer
- Testicular Cancer
- Thymoma (Thymic Carcinoma)
- Amegakaryocytosis
- Aplastic Anemia (Severe)
- Blackfan-Diamond Anemia
- Congenital Cytopenia
- Congenital Dyserythropoietic Anemia
- Dyskeratosis Congenita
- Fanconi Anemia
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Pure Red Cell Aplasia
- Beta Thalassemia Major
- Sickle Cell Disease
- Familial Erythrophagocytic Lymphohistiocytosis
- Hemophagocytosis
- Langerhans' Cell Histiocytosis (Histiocytosis X)
- Acute Myelofibrosis
- Agnogenic Myeloid Metaplasia (Myelofibrosis)
- Amyloidosis
- Chronic Myelomonocytic Leukemia (CMML)
- Essential Thrombocythemia
- Polycythemia Vera
- Refractory Anemias (RA) including:
- Refractory Anemia with Excess Blasts (RAEB)
- Refractory Anemia with Excess Blasts in Transformation (RAEB-T)
- Refractory Anemia with Ringed Sideroblasts (RARS)
- Adrenoleukodystrophy
- Fucosidosis
- Gaucher Disease
- Hunter Syndrome (MPS-II)
- Hurler Syndrome (MPS-IH)
- Krabbe Disease
- Lesch-Nyhan Syndrome
- Mannosidosis
- Maroteaux-Lamy Syndrome (MPS-VI)
- Metachromatic Leukodystrophy
- Mucolipidosis II (I-cell Disease)
- Neuronal Ceroid Lipofuscinosis (Batten Disease)
- Niemann-Pick Disease
- Sandhoff Disease
- Sanfilippo Syndrome (MPS-III)
- Scheie Syndrome (MPS-IS)
- Sly Syndrome (MPS-VII)
- Tay Sachs
- Wolman Disease
- Chronic Granulomatous Disease
- Congenital Neutropenia
- Leukocyte Adhesion Deficiency
- Severe Combined Immunodeficiencies (SCID) including:
- Adenosine Deaminase Deficiency
- Bare Lymphocyte Syndrome
- Chediak-Higashi Syndrome
- Kostmann Syndrome
- Omenn Syndrome
- Purine Nucleoside Phosphorylase Deficiency
- Reticular Dysgenesis
- Wiskott-Aldrich Syndrome
- X-Linked Lymphoproliferative Disorder
- Cartilage-Hair Hypoplasia
- Congenital Erythropoietic Porphyria (Gunther Disease)
- DiGeorge Syndrome
- Osteopetrosis
- Chronic Active Epstein Barr
- Evans Syndrome
- Multiple Sclerosis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Thymic Dysplasia
Emerging Stem Cell Applications
- Brain Injury
- Cerebral Palsy
- Type 1 Diabetes
- Heart Disease
This list includes some diseases that have been treated with bone marrow or peripheral blood stem cells but have not yet been treated with cord blood stem cells.
Refer to clinicaltrials.gov for additional information.
Not routinely eligible for CBR's Designated Transplant Program®
Source: Medical literature and clinicaltrials.gov.

